Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 532-536, February 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ho, Y. L.
Right arrow Articles by Ho, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ho, Y. L.
Right arrow Articles by Ho, S. K.

Screening of Carcinogens with the Prophage {lambda}clts857 Induction Test1

Yuk L. Ho2 and Shiu K. Ho

Departments of Microbiology and Medicine, Loma Linda University School of Medicine, Loma Linda, California 92350

The prophage {lambda}clts857 induction test with Escherichia coli K12 envA uvrB as the lysogen has been successfully applied to the screening of sparingly water-soluble carcinogens that have been dissolved in dimethyl sulfoxide and metabolically activated with liver enzymes induced either with Aroclor 1254 or phenobarbital. Growth of noninduced lysogenic cells during the test was suppressed with ampicillin, with resultant increase of sensitivity of the test. The maximum inducing activity observed was about 50% of the complete induction level attained with water-soluble carcinogens that did not require metabolic activation. High sensitivity was achieved with the use of the {lambda}clts857 prophage strain. In several instances where the Ames Salmonella-microsome test has failed to confirm the carcinogenicity of the respective carcinogens, this induction test has provided a better correlation. Of the carcinogens tested, only one false negative, namely, cyclophosphamide, was encountered. In contrast, the use of the wild-type prophage {lambda} strain resulted in low sensitivity. The adoption of the endolysin assay technique for the assessment of induction has greatly simplified the procedures and has permitted the screening test to be performed quickly and economically.

1 This work was supported in part by NIH Grants RR05352 and RR0276.

2 To whom requests for reprints should be addressed.

Received 6/11/80. Accepted 10/16/80.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.